معرفی
Jing Li serves as an Associate Professor in the Comparative Health Outcomes, Policy and Economics (CHOICE) Institute within the Department of Pharmacy at the University of Washington School of Pharmacy. Her research focuses on economic and behavioral mechanisms driving healthcare decision-making among providers and patients, with emphasis on policy interventions to improve outcomes and market efficiency.
Her educational background includes:
- PhD in Health Economics and MA in Economics from University of California, Berkeley
- MA in International Comparative Education from Stanford University
Methodologically pioneering in experimental and econometric approaches, Dr. Li's work uniquely measures social preferences (altruism) among U.S. medical professionals and links these to clinical practice and patient outcomes. Her research bridges health economics with behavioral science to address understudied questions in physician incentives, end-of-life care economics, and dementia-related financial impacts.
Her publication record reveals consistent contributions to top-tier journals including Proceedings of the National Academy of Sciences, Journal of Public Economics, and JAMA Neurology, demonstrating evolving expertise from physician altruism studies (2018-2022) to contemporary analyses of cancer drug marketing (2024) and Medicare advance care planning (2024). This trajectory shows increasing policy relevance in pharmaceutical economics and aging-related financial security.
Dr. Li has secured principal investigator funding from major institutions:
- National Institute on Aging (NIH)
- Agency for Healthcare Research and Quality (AHRQ)
- Weill Cornell Medicine
- Russell Sage Foundation
- Cornell Center for Social Sciences
As a core faculty member of the CHOICE Institute, she contributes to this collaborative research center dedicated to generating evidence for health outcomes improvement and policy optimization through economic analysis.
